Matulonis, Ursula A <br/><br/>
Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Dec 2008 
 - 5761-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2008.17.0282  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Boston<br/>Carboplatin--administration & dosage<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Fallopian Tube Neoplasms--drug therapy<br/>Female<br/>Glutamates--administration & dosage<br/>Guanine--administration & dosage<br/>Humans<br/>Infusions, Intravenous<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Ovarian Neoplasms--drug therapy<br/>Pemetrexed<br/>Peritoneal Neoplasms--drug therapy<br/>Time Factors<br/>Treatment Outcome